These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31691587)
1. Use of Biologics in Pityriasis Rubra Pilaris Refractory to First-Line Systemic Therapy: A Systematic Review [Formula: see text]. Naidoo A; Sibbald C; Fleming PJ; Piguet V J Cutan Med Surg; 2020; 24(1):73-78. PubMed ID: 31691587 [TBL] [Abstract][Full Text] [Related]
2. Biologics for pityriasis rubra pilaris treatment: A review of the literature. Napolitano M; Abeni D; Didona B J Am Acad Dermatol; 2018 Aug; 79(2):353-359.e11. PubMed ID: 29609014 [TBL] [Abstract][Full Text] [Related]
3. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation. Maloney NJ; Hisaw LD; Worswick S Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547 [TBL] [Abstract][Full Text] [Related]
4. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. Müller H; Gattringer C; Zelger B; Höpfl R; Eisendle K J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S65-70. PubMed ID: 19119128 [TBL] [Abstract][Full Text] [Related]
5. Treatment of pityriasis rubra pilaris type I: a systematic review. Engelmann C; Elsner P; Miguel D Eur J Dermatol; 2019 Oct; 29(5):524-537. PubMed ID: 31789274 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. Petrof G; Almaani N; Archer CB; Griffiths WA; Smith CH J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e131-5. PubMed ID: 22324561 [TBL] [Abstract][Full Text] [Related]
8. Treatment of pityriasis rubra pilaris: a case series of 28 patients. Kromer C; Lippert U; Schön MP; Mössner R Eur J Dermatol; 2020 Oct; 30(5):569-579. PubMed ID: 33021474 [TBL] [Abstract][Full Text] [Related]
9. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy? Ivanova K; Itin P; Haeusermann P Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris. Boyd AH; Polcari IC Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of pityriasis rubra pilaris with adalimumab - case report. Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310 [TBL] [Abstract][Full Text] [Related]
12. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review. Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719 [TBL] [Abstract][Full Text] [Related]
13. Management of refractory pityriasis rubra pilaris: challenges and solutions. Moretta G; De Luca EV; Di Stefani A Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428 [TBL] [Abstract][Full Text] [Related]